# Pleiades ENT Hospital

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/pleiades-ent-hospital

- Industry: Healthcare
- Headquarters: Wuhan, China
- Website: www.bdxetyy.com
- Latest round: Series A (Aug 16, 2018)
- Investors on record: 3

## About

Pleiades ENT Hospital, based in Wuhan, China, specializes in pediatric healthcare, providing a wide range of medical services for children and adolescents, particularly in ENT, surgery, neurology, and rehabilitation.Founded in 2017 in Wuhan, China, Pleiades ENT Hospital focuses on delivering specialized medical care for children. The hospital was established by CEO Hongwu Yao, who has a history of founding healthcare institutions. The hospital has completed 2 deals, with the most recent deal occurring on August 16, 2018.Pleiades ENT Hospital offers a comprehensive range of pediatric medical services, including specialties like Pediatric ENT, Pediatric Surgery, Neurology, and Rehabilitation Services. The hospital addresses various pediatric conditions, emphasizing early intervention for respiratory, digestive issues, and psychological services for conditions like ADHD and autism. Located in Wuchang and Optics Valley, the hospital primarily serves families in urban areas of Wuhan and surrounding cities.Pleiades ENT Hospital generates revenue by providing specialized healthcare directly to patients through outpatient consultations and inpatient treatments. Services are billed per visit, allowing for a clear transaction process. The hospital offers various pricing plans, particularly for pediatric surgery and psychological care, establishing direct relationships with families to ensure consistent revenue from its healthcare offerings.Following the Series A funding raised from Share Capital Partners in August 2018, Pleiades ENT Hospital plans to enhance its service offerings and expand into new markets. The hospital is working on developing additional pediatric specialties and aims to launch these services within the next two years. Expansion is targeted towards urban areas beyond Wuhan, aiming for a broader reach across major cities in China. Recent funding will support these initiatives, enabling the hospital to improve facilities and broaden its patient base.

## Funding rounds

- Series A, Aug 16, 2018 — Share Capital
- Angel, Dec 4, 2016 — Sharelink Capital, Weidu Capital

## Investors

- Sharelink Capital (https://capitalatlas.ai/funds/sharelink-capital) — Angel
- Weidu Capital (https://capitalatlas.ai/funds/weidu-capital) — Angel
- Share Capital (https://capitalatlas.ai/funds/share-capital) — Series A
